Mountain Group Partners

United States
Firm Location:United States • Nashville, Tennessee
Mountain Group Partners Team
Photo of Joe Cook III, Managing Director at Mountain Group Partners
Joe Cook III
Mountain Group Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in BioTech, Investors in Diagnostics
Photo of Joe Cook Jr, Managing Director at Mountain Group Partners
Joe Cook Jr
Mountain Group Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Rob Readnour, Managing Director at Mountain Group Partners
Rob Readnour
Mountain Group Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in Diagnostics, Investors in Pharmaceuticals
Photo of Steve Singleton, Managing Director at Mountain Group Partners
Steve Singleton
Mountain Group Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in BioTech, Investors in LegalTech
Photo of Jack Slaughter, Vice President at Mountain Group Partners
Jack Slaughter
Mountain Group Partners·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in BioTech, Investors in Pharmaceuticals
Photo of Byron Smith, Managing Director at Mountain Group Partners
Byron Smith
Mountain Group Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in AgTech, Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Enterprise Infrastructure, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT
Photo of Tyler Whitmore, Vice President at Mountain Group Partners
Tyler Whitmore
Mountain Group Partners·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Nashville (TN)
Investors in BioTech, Investors in Pharmaceuticals